All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Sudhir Kumar reports receipt of a speaker honorarium from the Tuberculosis Program, Bureau of Immunization & Tuberculosis, Iowa Department of Health and Human Services for a presentation on treatment of drug-susceptible tuberculosis. Angela Hewlett and Angela Vasa report receipt of a Regional Emerging Special Pathogen Treatment Center Cooperative Agreement for work on the Administration for Strategic Preparedness’ Response Catalog of Federal Domestic Assistance. Michael Pentella reports grants or contracts from GoDiagnostics and the Veterans Administration; consulting fees from the University of Hawaii; payment or honoraria from New England Clinical Microbiology and Quadrangle Group; support for meetings and travel from the Association for Biosafety and Biosecurity International and the Association of Public Health Laboratories (APHL); and service on the APHL Board of Directors. Shelly Schwedhelm reports grants or contracts from the National Emerging Special Pathogens Training & Education Center; unpaid membership on the Three Rivers Board of Health; and unpaid service as chair of the Omaha Metropolitan Healthcare Coalition 501c3 Board of Directors. Megan Nelson reports support for meetings or travel from APHL. No other potential conflicts of interest were disclosed.